ABFRL chart portrays positive picture
ABFRL chart portrays positive picture

ABFRL chart portrays positive picture

Vinayak Gangule Article rating: 5.0

The stock of Aditya Birla Fashion & Retail Limited (ABFRL) has gained over 10 per cent in the last two trading sessions. Read onto know more about what the technical chart of the stock indicates.

Chambal Fertilisers & Chemicals Ltd forms dark cloud cover pattern
Chambal Fertilisers & Chemicals Ltd forms dark cloud cover pattern

Chambal Fertilisers & Chemicals Ltd forms dark cloud cover pattern

Vinayak Gangule Article rating: 5.0

Moreover, there has been a negative divergence between the daily RSI, daily stochastic and the stock price movement, which suggests a limited upside. A negative divergence occurs when the price is making a higher high, while the indicators form a lower high.

Is RBI hinting towards hiking repo rates?
Is RBI hinting towards hiking repo rates?

Is RBI hinting towards hiking repo rates?

Henil Shah Article rating: 5.0

Though RBI maintained its accommodative stance in the MPC meeting, but do you think, it hints towards a further hike in repo rates in the future? Let’s find out. 

Consolidation pattern breakout & institution interest suggest stock may garner limelight again!
Consolidation pattern breakout & institution interest suggest stock may garner limelight again!

Consolidation pattern breakout & institution interest suggest stock may garner limelight again!

Karan Dsij Article rating: 4.1

As per O’Neil methodology, the buyer demand is A, which indicates strong institutional interest. The FPI/FPI investors have increased their holding from 30.59 in September 2020 quarter to 32.78 per cent in December 2020 quarter. Similarly, the mutual funds have increased holdings from 9.53 per cent in September 2020 quarter to 10.42 per cent in December 2020 quarter.

Biocon Biologics signs agreement to expand access of cancer biosimilars to over 30 countries
Biocon Biologics signs agreement to expand access of cancer biosimilars to over 30 countries

Biocon Biologics signs agreement to expand access of cancer biosimilars to over 30 countries

Anthony Fernandes Article rating: 4.3

Biocon Biologics, a fully-integrated biosimilars company and a subsidiary of Biocon Limited announced that it has signed an agreement with Clinton Health Access Initiative to expand access to lifesaving cancer biosimilars in over 30 countries in Africa and Asia as a part of Cancer Access Partnership (CAP).   

Know why one needs to exercise caution in BHEL despite witnessing outperformance
Know why one needs to exercise caution in BHEL despite witnessing outperformance

Know why one needs to exercise caution in BHEL despite witnessing outperformance

Karan Dsij Article rating: 4.6

Given the fact that the stock has started to outperform in the recent past on the back of a huge volume spike certainly indicates interest for this stock; however, it has reached a very crucial juncture. This juncture is known as a ‘change in polarity’. The principle of change in polarity states that once breached, a support level becomes resistance and vice-versa i.e. the resistance level becomes support. 

These stocks are witnessing spike in delivery volumes!
These stocks are witnessing spike in delivery volumes!

These stocks are witnessing spike in delivery volumes!

Karan Dsij Article rating: 4.0

One of the most crucial things that many of the market participants tend to overlook when they buy a stock for a short-term trading purpose or for an investment purpose is the delivery volume. The stocks that are a part of Nifty 500 are considered and the total volume traded should be greater than 1,00,000. Further, the total volume traded should be greater than the previous session.

RSS
First18471848184918501852185418551856Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR